Dallas, TX (PRWEB) September 30, 2011
Buyer Group International, Inc., (“BYRG.PK”) September 28, 2011 announces execution of documents with private parties committing to purchase $13.5 Million in share interest backed by worldwide receipts and ancillary rights of 12 existing Films and a new theatrical film “Blood Will Tell”, a major motion picture for worldwide theatrical release, with the first $500k expected in four to six weeks.
Secondary to selling interest in its projects, BYRG.PK has initiated a share exchange and buyback program for both active and street shareholders already recovering a total of 30.5 Billion shares with an approximate 2.8 Billion left to re-purchase or exchange. It is expected BYRG will be able to buyback most of its outstanding shares with an additional 2 Billion in exchanges pending, leaving less than a Billion outstanding.
In addition to the share exchanges, BYRG.PK plans to offer a 20% or a 6:5 exchange of preferred shares for common shares backed by worldwide receipts of Blood Will Tell and its library of films. Shareholders of the date of record, expected to be November 5 and subject to change, will receive the exchange and a 20% boost in dollar value of their shares, pending regulatory approval.
Information may be found at http://www.buyergroupint.com as it is released to the public.
News for BYRG is located at http://www.buyergroupint.com/news.html
Safe Harbor Statement - This release includes forward-looking statements within the meaning of Section 27A & 27E of the Securities Act of 1933, 1934. Statements herein that are not historical facts are deemed forward-looking statements based upon management's current expectations. Investors are cautioned that forward-looking statements are inherently uncertain and subject to risks and uncertainties that could cause actual results to differ materially from those set forth and management undertakes no obligation to update or revise such statements. Actual performance results may differ materially from those suggested herein due to uncertainties including, without limitation, ability to obtain financing, regulatory and shareholder approval, and the ability to attract or retain key management personnel.